Pre surgery assessment and surgical outcomes after high risk cases of abdominal cancers
Not Applicable
Completed
- Conditions
- Health Condition 1: C220- Liver cell carcinomaHealth Condition 2: C18- Malignant neoplasm of colonHealth Condition 3: C23- Malignant neoplasm of gallbladderHealth Condition 4: C25- Malignant neoplasm of pancreasHealth Condition 5: C19- Malignant neoplasm of rectosigmoidjunctionHealth Condition 6: C20- Malignant neoplasm of rectumHealth Condition 7: C17- Malignant neoplasm of small intestineHealth Condition 8: C16- Malignant neoplasm of stomach
- Registration Number
- CTRI/2021/01/030492
- Lead Sponsor
- Tata Memorial Hospital Mumbai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 745
Inclusion Criteria
Gastro-intestinal cancers with American society of anesthesiologist class 1-4, having high risk (surgical or anaesthesia risk) and assessed in preoperative high risk joint clinic
Exclusion Criteria
Patients with incomplete or no data
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative complications as per Clavien Dindo class of complicationsTimepoint: From day of surgery to 30 days postoperatively
- Secondary Outcome Measures
Name Time Method eed for postoperative ventilation, number of days of ventilation, number of days in ICU, number of stay in hospital, Re-admission in ICU and readmission in hospital and 30 daysâ?? all-cause mortality.Timepoint: From day of surgery to 30 days postoperatively
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular biomarkers correlate with improved perioperative outcomes in high-risk gastrointestinal cancer surgeries?
How does preoperative optimization impact survival rates in patients with C220 liver cell carcinoma undergoing surgery?
Are there specific adverse events associated with surgical interventions for C16 malignant neoplasm of the stomach in high-risk patients?
What are the comparative effectiveness strategies for postoperative care in C25 pancreatic cancer versus other gastrointestinal cancers?
Which drug classes show potential for adjuvant therapy in C19 rectosigmoid junction malignancies based on recent clinical insights?